ARTICLES BY THIS AUTHOR
- 5/26/2021
Upsher-Smith, Rafarm intro generic Vigamox
The moxifloxacin ophthalmic solution had a market value of approximately $34 million for the 12 months ended March 2021, according to IQVIA. - 5/26/2021
FDA grants emergency use authorization for GSK’s COVID-19 treatment
The authorization allows Sotrovimab to be distributed and administered as a 500 mg single dose intravenously by healthcare providers. - 5/25/2021
McKesson combining 4 tech, automation businesses under CoverMyMeds brand
The unified strategy for RelayHealth, McKesson Prescription Automation, CoverMyMeds and RxCrossroads by Mckesson is intended to create a cohesive experience for customers, patients and employees. - 5/25/2021
Schnuck Markets kicks off 4th-annual Folds of Honor 'Round Up at the Register' campaign
Schnucks' teammates, vendors, and customers have raised $3.2 million and funded 620 scholarships for Folds of Honor since 2018. - 5/25/2021
DIR reform act gains praise from FMI
If passed, the legislation would require pharmacy-negotiated price concessions, payment and fees to be included in negotiated prices at the point-of-sale under Part D of the Medicare program. - 5/25/2021
PQS, Humana to expand diabetes outcomes pilot to pharmacies nationwide
Humana and Pharmacy Quality Solutions are expanding the EQuIPP platform-based program, enabling more pharmacists to provide enhanced support to patients managing their diabetes goals. - 5/24/2021
Moderna study finds vaccine highly effective in preventing COVID-19 in adolescents
Moderna plans to submit data to the FDA in early June and request authorization. - 5/24/2021
NACDS hails Indiana law, saying it expands access to pharmacy-based care
The new law empowers pharmacists to optimize patient-centered care models, advance access to immunizations, essential medications, and more. - 5/24/2021
Camber debuts generic Strattera
Camber's generic Strattera provides a treatment for attention-deficit hyperactivity disorder. - 5/23/2021
FDA clears Glenmark’s generic Firazyr
Firazyr injection had a market value of roughly $223.4 million for the 12 months ended March 2021, according to IQVIA.